Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Asparagine
2. L-asparagine
1. 3130-87-8
2. Asparagine, Dl-
3. 2,4-diamino-4-oxobutanoic Acid
4. H-asn-oh Ho
5. 2-amino-3-carbamoylpropanoic Acid
6. 7006-34-0
7. Nsc7891
8. (-)-asparagine; Asn; Asparamide
9. Nsc82391
10. Wln: Zv1yzvq
11. H-dl-asn-oh
12. Asparagine #
13. Asparagin
14. Dl-aspartic Acid 4-amide
15. L-(+)-asparagine
16. L-.beta.-asparagine
17. Asparagina
18. Hasp
19. Dl-aspartamine
20. Mfcd00008036
21. (+-)-asparagine
22. L-asparagine-15n2
23. Asparagine, Dl
24. 2-amino-succinamic Acid
25. Asparagine, (l)
26. H-dl-asn-oh?2o
27. H-d-asn-oh . Ho
28. (s)-2,4-diamino-4-oxobutanoic Acid Hydrate
29. Schembl2308617
30. Chebi:22653
31. Dtxsid30859927
32. Nsc 7891
33. Nsc-7891
34. Einecs 221-521-1
35. Mfcd00064400
36. Nsc206243
37. Stl277093
38. Akos000120782
39. Akos016050525
40. Cs-w018158
41. Hy-w017442
42. Nsc 206243
43. Nsc-206243
44. Butanoic Acid,4-diamino-4-oxo-, (s)-
45. Ls-12998
46. Sy008178
47. Sy014875
48. Db-020547
49. A0541
50. Ft-0602581
51. Ft-0627706
52. A15665
53. F10838
54. Ab00443949-02
55. 130a878
56. 4-(3-nitroanilino)-4-oxobut-2-enoicacid
57. Q185906
58. Sr-01000944855
59. Sr-01000944855-1
60. Z278101788
61. B62f87a0-7aa2-4b41-8f86-34b7856972aa
| Molecular Weight | 132.12 g/mol |
|---|---|
| Molecular Formula | C4H8N2O3 |
| XLogP3 | -3.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 132.05349212 g/mol |
| Monoisotopic Mass | 132.05349212 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 134 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Topical
Controlled & Modified Release
Fillers, Diluents & Binders
Film Formers & Plasticizers
Coating Systems & Additives
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Asparagine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Asparagine manufacturer or Asparagine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Asparagine manufacturer or Asparagine supplier.
PharmaCompass also assists you with knowing the Asparagine API Price utilized in the formulation of products. Asparagine API Price is not always fixed or binding as the Asparagine Price is obtained through a variety of data sources. The Asparagine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ASPARAGINE, (L) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ASPARAGINE, (L), including repackagers and relabelers. The FDA regulates ASPARAGINE, (L) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ASPARAGINE, (L) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ASPARAGINE, (L) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ASPARAGINE, (L) supplier is an individual or a company that provides ASPARAGINE, (L) active pharmaceutical ingredient (API) or ASPARAGINE, (L) finished formulations upon request. The ASPARAGINE, (L) suppliers may include ASPARAGINE, (L) API manufacturers, exporters, distributors and traders.
click here to find a list of ASPARAGINE, (L) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ASPARAGINE, (L) CEP of the European Pharmacopoeia monograph is often referred to as a ASPARAGINE, (L) Certificate of Suitability (COS). The purpose of a ASPARAGINE, (L) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of ASPARAGINE, (L) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of ASPARAGINE, (L) to their clients by showing that a ASPARAGINE, (L) CEP has been issued for it. The manufacturer submits a ASPARAGINE, (L) CEP (COS) as part of the market authorization procedure, and it takes on the role of a ASPARAGINE, (L) CEP holder for the record. Additionally, the data presented in the ASPARAGINE, (L) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the ASPARAGINE, (L) DMF.
A ASPARAGINE, (L) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. ASPARAGINE, (L) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of ASPARAGINE, (L) suppliers with CEP (COS) on PharmaCompass.
ASPARAGINE, (L) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ASPARAGINE, (L) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ASPARAGINE, (L) GMP manufacturer or ASPARAGINE, (L) GMP API supplier for your needs.
A ASPARAGINE, (L) CoA (Certificate of Analysis) is a formal document that attests to ASPARAGINE, (L)'s compliance with ASPARAGINE, (L) specifications and serves as a tool for batch-level quality control.
ASPARAGINE, (L) CoA mostly includes findings from lab analyses of a specific batch. For each ASPARAGINE, (L) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ASPARAGINE, (L) may be tested according to a variety of international standards, such as European Pharmacopoeia (ASPARAGINE, (L) EP), ASPARAGINE, (L) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ASPARAGINE, (L) USP).
